Pharmaceutical Study on Brihat Madhusnuhi Rasayana and Its Organoleptic Evaluation
DOI:
https://doi.org/10.70066/jahm.v7i6.11Keywords:
Brihat Madhusnuhi Rasayana, Lehya kalpana, Pakasiddhi, organoleptic evaluationAbstract
Brihat Madhusnuhi Rasayana is a classical formulation mentioned in Sahasrayoga under Lehya kalpana.Madhusnuhi is the prime drug in this recipe followed by other important ingredients like Shuddha gandhaka-Shuddha guggulu etc which are known for their good kushtaghna-twachya-rasayana and shoolahara effects. Due to its dosage form of Lehya, it further adds up the rasayana properties due to significant amount of ghee and sugar candy; thus the formulation becomes most apt top administer in chronic diseased conditions of various conditions like chronic wounds and ulcers, degenerative arthritis, steroid dependent skin diseases, non healing ulcers, fistula and sinus conditions etc. The formulation was prepared to evaluate its pharmaceutical feasibility, organo-leptic evaluation and hence to find out the possibilities to large scale manufacturing and hence marketing.
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Dr M S Krishnamurthy Suvacha Ayurveda
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.
